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Objectives In participants with peripheral arterial disease (PAD), we determined whether more sedentary behavior and
slower outdoor walking speed were associated with faster functional decline and more adverse changes in calf
muscle characteristics over time.
Background Modifiable behaviors associated with faster functional decline in lower-extremity PAD are understudied.
Methods Participants were 384 men and women with an ankle brachial index 0.90 followed for a median of 47
months. At baseline, participants reported the number of hours they spent sitting per day and their walking
speeds outside their homes. Participants underwent baseline and annual measures of objective functional perfor-
mance. Calf muscle characteristics were measured with computed tomography at baseline and every 2 years subse-
quently. Analyses were adjusted for age, sex, race, comorbidities, ankle brachial index, and other confounders.
Results Slower walking speed outside the home was associated with faster annual decline in calf muscle density (brisk/
striding pace 0.32 g/cm3, average pace 0.46 g/cm3, casual strolling 1.03 g/cm3, no walking at all
1.43 g/cm3, p trend 0.001). Greater hours sitting per day were associated with faster decline in 6-min walk
(4 h: 35.8 feet/year; 4 to 7 h: 41.1 feet/year; 8 to 11 h: 68.7 feet; 12 h: 78.0 feet; p trend 
0.008). Similar associations were observed for greater hours sitting per day and faster declines in fast-paced
(p trend  0.018) and usual-paced (p trend  0.001) 4-m walking velocity.
Conclusions Greater sedentary hours per day and slower outdoor walking speed are modifiable behaviors that are associated
with faster functional decline and greater decline in calf muscle density, respectively, in patients with PAD.
(J Am Coll Cardiol 2011;57:2356–64) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2010.12.038Men and women with lower-extremity peripheral arterial
disease (PAD) have greater functional impairment and
faster functional decline compared with those without PAD
(1–3). Few therapies have been identified that improve
functional performance in men and women with PAD.
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2010, accepted December 6, 2010.Although supervised treadmill exercise improves treadmill
walking endurance in patients with PAD (4), medical
insurance does not typically cover supervised treadmill
exercise and few patients with PAD participate (5).
See page 2365
Few data are available regarding associations of modifi-
able lifestyle behaviors with functional decline and other
important outcomes in people with PAD. Therefore, in a
prospective, observational study, we assessed associations of
the number of sedentary hours per day with rates of
functional decline and changes in calf muscle characteristics
among men and women with PAD. We also studied
associations of outdoor walking speed with functional de-
cline and changes in calf muscle characteristics among
participants with PAD. We hypothesized that more seden-
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June 7, 2011:2356–64 Sedentary Behavior and Functional Decline in PADtary hours per day and slower walking speed outside the
home would be associated with faster functional decline and
more adverse calf muscle changes over time among men and
women with PAD.
Methods
Study overview. The institutional review boards of North-
western University and Catholic Health Partners Hospital
approved the protocol. Participants gave written informed
consent. Participants were enrolled in the WALCS (Walk-
ing and Leg Circulation Study) II cohort, a prospective,
observational study designed to identify mechanisms of
functional decline in PAD (6,7). Participants underwent
baseline measures and returned annually for up to 4
follow-up visits.
Participant identification. Recruitment, participation
rates, and exclusion criteria for the WALCS II cohort have
been described (6,7) and are summarized briefly here.
Participants were age 59 years and older and were identified
from among consecutive patients diagnosed with PAD in
Chicago-area noninvasive vascular laboratories (5,6). A
small number of participants with PAD were identified
from among consecutive patients in a large general internal
medicine practice at Northwestern University. PAD was
defined as ankle brachial index (ABI) 0.90 (6,7). Patients
with dementia were excluded because of their inability to
answer questions accurately. Nursing home residents,
wheelchair-bound patients, and patients with foot or leg
amputations were excluded because they had severely im-
paired functioning at baseline. Non–English-speaking pa-
tients were excluded because investigators were not fluent in
non-English languages. Patients with recent major surgery
were excluded.
ABI measurement. A handheld Doppler probe (Nicolet
Vascular Pocket Dop II, Nicolet Biomedical Inc, Golden,
Colorado) was used to measure systolic pressures in the
right and left brachial, dorsalis pedis, and posterior tibial
arteries (6–8). Each pressure was measured twice. For each
leg, the ABI was calculated by dividing the mean of the
dorsalis pedis and posterior tibial pressures by the mean of
the 4 brachial pressures (8). Zero values for the dorsalis
pedis and posterior tibial pulses were set to missing for the
ABI calculation. Average brachial pressures in the arm with
the highest pressure were used when 1 brachial pressure was
higher than the opposite brachial pressure in both measure-
ment sets and the 2 brachial pressures differed by 10 mm Hg
or more in at least 1 measurement set. In these cases,
subclavian stenosis was possible (9). The leg with the lowest
ABI was used in analyses.
Measures of sedentary hours per day and participant-
reported walking speed outside the home. At baseline,
participants were asked, “In a typical day, how many hours
do you spend sitting? Be sure to include time spent sitting
at a desk, riding in a car, eating, and sitting up watching
television” (10,11). Participants were also asked, “In a otypical day, how many hours do
you spend lying down? Include
time spent sleeping, lying down
resting, napping, and trying to
get to sleep” (10). Based on re-
sponses to these questions, we
calculated: 1) the number of
hours spent sitting per day; and
2) the total number of sedentary
hours per day (including hours
spent sitting and lying down). At baseline, participants were
asked to describe their typical walking speed when walking
outside their house. Specifically, participants were asked,
“When you walk outside your house, what is your usual
walking speed?” (10). Participants selected from one of the
following responses: 1) no walking at all; 2) casual strolling
(0 to 2 miles/h); 3) average or normal (2 to 3 miles/h); and
4) brisk or striding (3 miles/h).
Functional outcomes. Functional outcomes were assessed
at baseline and annually and consisted of average annual
declines in 6-min walk performance, usual-paced 4-m
walking velocity, and fastest-paced 4-m walking velocity.
6-MIN WALK. The 6-min walk test is a validated and reliable
measure of walking performance that predicts mortality,
mobility loss, and correlates significantly with physical
activity levels during daily life (12–15). Following a stan-
dardized protocol (12–15), participants walk up and down a
100-foot hallway for 6 min after instructions to cover as
much distance as possible.
4-M WALKING VELOCITY. Walking velocity was measured
with a 4-m walk performed at “usual” and “fastest” paces,
based on a previous study (14–16). Each walk was per-
formed twice. The faster walk in each pair was used in
analyses (14–16).
Calf muscle characteristics. Calf muscle measurements
were assessed with computed tomography (CT) at baseline
and at the 2- and 4-year follow-up visits using a CT scanner
(LightSpeed, General Electric Medical Systems, Waukesha,
Wisconsin) (6,7). Cross-sectional (2.5 mm) images of the
calves were obtained at 66.7% of the distance from the distal
to the proximal tibia (6,7). Cross-sectional images were
analyzed using BonAlyse (BonAlyse Oy, Jyvaskyla, Fin-
land), a software for processing CT images that identifies
muscle tissue, fat, and bone (6,7,17). The muscle outline
was traced manually, excluding subcutaneous fat and bone.
When quantifying muscle area, the BonAlyse software
quantifies voxels within a range corresponding to muscle
density (9 to 271 mg/cm3) and excludes voxels correspond-
ing to fat density (270 to 8 mg/cm3) (6,7). Intramuscular
fat is quantified by summing voxels corresponding to fat
within muscle tissue. Muscle density measures the quantity
of muscle per volume within the voxel range corresponding
to muscle (9 to 271 mg/cm3) and is a measure of muscle
uality (6,7). Cadaver studies demonstrate that these meth-
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cause larger individuals require greater muscle mass to
support their frames, muscle area was adjusted for the square
of individual tibia length (6,7).
Comorbidities. Comorbidities assessed at baseline were
diabetes, angina, myocardial infarction, heart failure, cancer,
chronic lung disease, lower-extremity arthritis, spinal steno-
sis, spinal disc disease, and stroke (19). Disease-specific
algorithms that combine data from patient report, medical
record review, medications, laboratory values, and a ques-
tionnaire completed by the participant’s primary care phy-
sician were used to verify and document baseline comor-
bidities other than knee and hip arthritis, based on criteria
previously developed (20). American College of Rheuma-
tology criteria were used to document presence of knee and
hip osteoarthritis (21,22).
Physical activity measurement using the Caltrac vertical
accelerometer. We used a vertical accelerometer (Caltrac,
Muscle Dynamics Fitness Network, Inc., Torrence, Cali-
fornia) to measure physical activity continuously over 7 days
using previously described methods (23,24). Vertical accel-
erometers do not measure activities performed standing or
sitting that do not involve vertical motion. Test-retest
reliability of the Caltrac vertical accelerometer is excellent
among participants with PAD (25). We programmed the
accelerometer identically for all participants, allowing us to
compare physical activity levels among participants, irre-
spective of individual variation in age, weight, height, and
sex (23,24). Programmed in this way, the accelerometers
measured “activity units.”
Other measures. Height and weight were measured at
baseline. Body mass index (BMI) was calculated as: weight
(kg)/(height [m])2. Cigarette smoking history was deter-
ined with patient report. At each follow-up visit, we used
atient report, a primary care physician questionnaire, and
edical record review to identify lower-extremity revascu-
arizations since the previous visit.
tatistical analyses. Before data analyses, categories of the
umber of hours spent sitting per day were defined as
ollows, based on the distribution of baseline data: 1) 4
/day; 2) 4 to 7 h/day; 3) 8 to 11 h/day; and 4) 12
/day. Before data analyses, categories of the total number
f sedentary hours per day (including hours spent either
itting or lying down) were defined as follows: 1) 10
/day; 2) 10 to 14 h/day; 3) 14 to 18 h/day; and 4) 18
/day. Analysis of covariance (ANCOVA) was used to
ompare continuous baseline clinical characteristics across
ategories of number of sedentary hours per day and across
ategories of participant-reported walking intensity, with
djustments for age. Logistic regression was used to com-
are categorical baseline characteristics across categories of
edentary hours, with adjustments for age. Spearman cor-
elation coefficients were calculated between the Caltrac
ertical accelerometer value and measures of total hours
pent sitting per day, total hours spent sedentary per day,
nd walking speed outside the home.Changes in functional performance (6-min walk distance
nd 4-m walking velocity) and calf muscle characteristics
calf muscle density, calf muscle area, and calf muscle
ercent fat) were compared across categories of 1) hours
pent sitting per day; 2) total sedentary hours (both sitting
nd lying down) per day; and 3) participant-reported walk-
ng speed outside the home using a longitudinal or
epeated-measure ANCOVA and a mixed-model approach.
ROC MIXED with the command “repeat” was used to
erform these analyses. Participants who underwent lower-
xtremity revascularization were excluded from analyses
fter the date of their lower-extremity revascularization.
he within-subject correlations were modeled with a
ubject-specific random effect. The primary dependent vari-
bles for each analysis were the successive annual differences
n each outcome of interest (i.e., the difference in 6-min
alk distance between baseline and the first follow-up visit,
etween the first and second follow-up visits, between the
econd and third follow-up visits, and so on). Differences in
ecline for each outcome were compared using ANCOVA,
djusting for baseline age, sex, race, BMI, smoking, ABI,
hysical activity, comorbidities, leg symptoms, and the
orresponding prior year performance or muscle character-
stic. A statistical test for trend was performed to determine
he degree to which the associations of each independent
ariable of interest with each dependent variable were linear.
airwise statistical comparisons were made between a ref-
rence category (least sedentary hours and fastest outdoor
alking speed, respectively) and each remaining category of
edentary hours and outdoor walking speed. Analyses of
hanges in muscle area included adjustment for tibia length.
nalyses were performed using SAS statistical software
version 9.2, SAS Institute Inc., Cary, North Carolina).
esults
mong 463 WALCS II participants with PAD, 384 were
ligible for the current analyses. Among the 79 participants
ith PAD not included, 2 participants did not complete
aseline questions regarding their walking speed outside the
ome or number of hours spent sitting and lying down per
ay. Ten participants had missing data relevant to our fully
djusted models, and 67 participants were not eligible for
nalyses because they did not return for at least 1 follow-up
isit or they underwent lower-extremity revascularization
efore their first follow-up visit. Median follow-up was 47
onths (interquartile range: 25 to 50 months).
Spearman correlation coefficients of vertical accelerometer–
easured physical activity with sitting hours per day and
otal sedentary hours per day were 0.077 (p  0.239) and
0.155 (p  0.017), respectively. The Spearman correla-
ion coefficient of vertical accelerometer–measured physical
ctivity and participant-reported walking speed outside the
ome was 0.281 (p  0.001). The Spearman correlation
coefficient between the number of hours sitting per day and
total sedentary hours per day was 0.892 (p  0.001). The
y
t
s
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June 7, 2011:2356–64 Sedentary Behavior and Functional Decline in PADSpearman correlation coefficients between participant-reported
walking speed outside the home and total hours sitting per day
as well as total hours spent lying down per day were 0.106
(p  0.039) and 0.161 (p  0.002), respectively.
Average ages across categories of total hours spent sitting
per day were 4 h: 73.0  7.8 years; 4 to 7 h: 75.5  7.9
Age-Adjusted Associations of Baseline Characteristics With the Nuand Total Sedentary Hour per Day Among Partic pants With P riphTable 1 Age-Adjusted Associ tions of B seline Charac eristicsand Total Sedentary Hours per Day Among Participant
Total Hours Sitting per Day <4 h
No. of patients 60
Body mass index, kg/m2 27.0 0.65 2
Ankle brachial index 0.66 0.02 0
Male, % 54.0
African American, % 17.2
Current smoker, % 17.4
Diabetes, % 26.2
Pulmonary disease, % 24.3
Cancer, % 21.9
Hip arthritis, % 0.00
Knee arthritis, % 10.2
Disc disease, % 39.8
Spinal stenosis, % 17.1
Angina, % 33.1
Myocardial infarction, % 18.6
Stroke, % 21.1
Heart failure, % 28.5
Calf muscle area, mm2 5,526 181 5,4
Calf muscle fat, % 10.2 1.71 1
Calf muscle density, g/cm3 32.4 0.54 3
6-min walk distance, feet 1,196 50.1 1,1
4-m usual-paced walking velocity, m/s 0.88 0.03 0
4-m fastest-paced walking velocity, m/s 1.16 0.04 1
Total Sedentary Hours per Day
(Sitting and Lying Down) <10 h 10 to
No. of patients 37 148
Body mass index, kg/m2 27.4 0.83 28.0
Ankle brachial index 0.66 0.03 0.62
Male, % 49.5 47
African American, % 22.3 19
Current smoker, % 23.0 11
Diabetes, % 18.3 38
Pulmonary disease, % 36.6 39
Cancer, % 19.4 17
Hip arthritis, % 2.82 4
Knee arthritis, % 11.4 15
Disc disease, % 56.7 37
Angina, % 26.6 30
Myocardial infarction, % 19.3 26
Stroke, % 20.7 17
Heart failure, % 35.7 24
Calf muscle area, mm2 5,459 231 5,492
Calf muscle fat, % 10.3 2.19 12.4
Baseline muscle density, g/cm3 31.7 0.69 32.8
Baseline 6-min walk, feet 1,167 64.4 1,152
Baseline 4-m usual pace, m/s 0.85 0.03 0.88
Baseline 4-m fast pace, m/s 1.16 0.05 1.17Data are presented as n, mean  SD, or %. N  384.years; 8 to 11 h: 74.0  8.6 years; and 12 h: 74.5  6.8
ears (p trend  0.832). Average ages across categories of
otal hours spent sedentary per day (combining time spent
itting and lying down) were 10 h: 71.9  8.5 years; 10 to
14 h: 75.6  7.8 years; 14 to 18 h: 73.3  8.5 years; and
18 h: 75.2  7.6 years (p trend  0.518). Table 1 shows
of Hours Spent SeatedArterial Diseaseth N mber of Hours Spent Seated
h Peripheral Arterial Disease
8–11 h >12 h p Trend
111 50
0.39 28.3 0.48 29.8 0.71 0.006
0.01 0.64 0.01 0.64 0.02 0.833
62.9 58.1 0.136
12.0 15.7 0.310
13.6 15.2 0.728
26.6 45.9 0.226
42.9 50.0 0.030
14.5 22.0 0.552
5 3.59 7.94 0.146
10.7 13.8 0.965
31.5 50.0 0.993
10.6 25.7 0.339
31.5 58.0 0.012
26.2 38.0 0.063
14.2 36.0 0.262
26.2 38.0 0.401
108 5,606 132 5,597 201 0.497
1.03 10.9 1.26 12.1 1.90 0.629
0.32 33.1 0.39 31.9 0.60 0.819
30.0 1,132 37.0 912 53.9 0.001
0.02 0.89 0.02 0.77 0.03 0.054
0.02 1.18 0.03 1.09 0.04 0.314
14 to <18 h >18 h p Trend
103 96
28.4 0.50 28.5 0.52 0.252
0.62 0.02 0.65 0.02 0.531
64.4 56.8 0.079
11.8 15.6 0.163
15.3 15.3 0.843
23.9 40.0 0.252
36.3 55.6 0.025
25.5 15.5 0.909
2.95 6.09 0.519
10.8 11.0 0.429
38.8 40.6 0.442
32.8 44.9 0.016
23.5 36.3 0.052
16.1 29.3 0.108
29.3 32.1 0.557
5,616 137 5,485 144 0.831
10.7 1.30 10.3 1.36 0.415
32.8 0.41 32.9 0.43 0.317
1,197 38.5 992 40.0 0.008
0.89 0.02 0.82 0.02 0.197
1.20 0.03 1.11 0.03 0.294mbereralWith
s Wit
4–7 h
163
8.0
.61
47.9
20.4
13.8
35.5
46.5
20.7
5.3
14.6
43.7
12.1
29.6
28.0
19.8
27.5
39
1.5
2.8
64
.87
.17
<14 h
 0.42
 0.01
.4
.9
.4
.1
.6
.3
.56
.4
.2
.6
.1
.8
.1
 114
 1.08
 0.34
 31.5
 0.02
 0.02
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according to the number of hours spent sitting per day and
the total sedentary hours (sitting and lying down) per day.
Greater hours sitting per day and greater total sedentary
hours per day were associated with higher prevalence of
pulmonary disease and angina. Greater hours sitting per day
were associated with higher BMI. Greater hours sitting and
greater total sedentary hours per day were each associated
with poorer 6-min walk performance at baseline (Table 1).
Average ages across categories of walking speed outside
the home were no walking at all: 76.0  8.1 years; casual
strolling: 75.6  7.6 years; average or normal: 73.5  8.2
years; and brisk or striding: 70.4  7.9 years (p trend
0.001). After adjustment for age, slower walking speed
outside the home was associated with higher BMI and
lower ABI values and higher prevalence of disc disease,
spinal stenosis, hip arthritis, angina, myocardial infarction,
and heart failure (Table 2). Slower walking speed outside
the home was associated with more adverse baseline calf
muscle characteristics and poorer performance on each
measure of baseline walking performance (Table 2).
Figure 1 shows associations of the number of hours
sitting per day with average annual decline in functional
performance. Greater hours sitting per day at baseline was
associated with greater average annual decline in 6-min walk
performance (p trend  0.008), usual-paced 4-m walking
velocity (p trend 0.001), and fast-paced 4-m walking
velocity (p trend  0.018), with adjustments for age, sex,
Age-Adjusted Associations of Baseline Characteristics With ReportOutside th Home Among Participants With Peripheral Arterial DiseTable 2 Age-Adjusted Asso ations of B s l ne CharacteristicsOutside the Home Among Participants With Peripheral
No Walking
Outside the Home
(n  16)
Casual St
(0–2 mile
(n  19
Body mass index, kg/m2 29.3 1.26 28.6
Ankle brachial index 0.55 0.04 0.62
Male, % 44.6 52.5
African American, % 44.9 15.4
Current smoker, % 19.0 15.0
Diabetes, % 32.3 35.3
Pulmonary disease, % 44.4 47.2
Cancer, % 18.4 17.5
Hip arthritis, % 12.1 6.9
Knee arthritis, % 11.6 14.4
Disc disease, % 62.9 42.9
Spinal stenosis, % 42.7 16.2
Angina, % 37.9 40.4
Myocardial infarction, % 31.1 32.3
Stroke, % 12.7 23.6
Heart failure, % 25.0 34.5
Baseline muscle area, mm2 4,700 333 5,341
Baseline fat percentage, % 19.4 3.18 12.6
Baseline muscle density gm/cm3 31.1 0.99 32.1
Baseline 6-min walk, feet 680 96 990
Baseline 4-m usual pace, m/s 0.65 0.05 0.81
Baseline 4-m fast pace, m/s 0.89 0.07 1.09Data are presented as mean  SD or %. N  381.race, BMI, comorbidities, smoking, study cohort, leg symp-
toms, ABI, and prior year performance. Figure 2 shows
associations of the total sedentary hours per day (both
sitting and lying down) with average annual decline in
functional performance. Greater total sedentary hours/day
at baseline were associated with greater average annual
decline in 6-min walk performance (p trend  0.010),
usual-paced 4-m walking velocity (p trend 0.001), and
fast-paced 4-m walking velocity (p trend  0.041), with
adjustments for age, sex, race, BMI, comorbid diseases,
smoking, study cohort, leg symptoms, ABI, and prior year
performance. There were no significant associations of
walking speed outside the home with average annual decline
in 6-min walk performance, usual-paced 4-m walking
velocity, or fastest-paced 4-m walking velocity (data not
shown).
We observed no significant associations of hours spent
sitting per day or total sedentary hours per day with average
annual change in calf muscle characteristics (Table 3).
However, slower walking speed outside the home was
associated with greater average annual decline in calf muscle
density (p trend 0.001), with adjustments for age, sex,
race, comorbidities, BMI, smoking, study cohort, leg symp-
toms, prior year calf muscle density, and ABI. Participants
with PAD who walked at a casual strolling pace outside the
home had significantly greater decline in calf muscle den-
sity, compared with participants with a brisk or striding pace
(p  0.025) (Table 3). In fully adjusted analyses, the
alking SpeedReported Walking Speed
rial Disease
Average or Normal
(2–3 miles/h)
(n  142)
Briskly or Striding
(>3 miles/h)
(n  26) p Trend
27.5 0.42 27.4 1.00 0.032
0.64 0.01 0.73 0.03 0.001
54.4 75.2 0.076
17.4 9.85 0.131
15.3 5.25 0.267
31.3 15.4 0.094
34.7 44.2 0.141
20.6 27.9 0.255
0.0 0.0 0.001
10.6 8.56 0.317
37.1 26.1 0.018
9.21 8.36 0.002
24.4 37.4 0.051
21.9 11.8 0.010
19.3 7.04 0.169
22.5 15.4 0.019
5,710 114 6,197 268 0.001
8.88 1.09 8.73 2.56 0.001
33.4 0.34 34.6 0.80 0.001
1,281 28 1,579 67.0 0.001
0.93 0.02 1.04 0.04 0.001
1.25 0.02 1.38 0.05 0.001ed WaseWith
Arte
rolling
s/h)
7)
0.36
0.01
3
97.6
0.93
0.29
24
0.01
0.02
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June 7, 2011:2356–64 Sedentary Behavior and Functional Decline in PADassociation of slower walking speed outside the home with
greater calf muscle density decline remained statistically
significant even after participants who reported no outdoor
walking (casual strolling: 1.05 g/cm3; average or normal:
0.46 g/cm3; brisk or striding: 0.331 g/cm3; p  0.001)
were excluded from the analyses. In these latter analyses,
participants with PAD who reported a walking speed of
“casual strolling” outside the home had significantly greater
decline in calf muscle density than those who reported a
walking speed of brisk or striding (p  0.024).
Discussion
Among 384 participants with PAD, greater hours spent
sitting per day and greater total sedentary hours per day
(both sitting and lying down) were associated with greater
average annual declines in 6-min walk performance, usual-
paced 4-m walking velocity, and fastest-paced walking
velocity. These associations were independent of potential
confounders including age, sex, race, comorbidities, BMI,
and ABI.
Patients with PAD experience significantly faster rates of
functional decline and mobility loss compared with those
Figure 1 Adjusted Associations of Hours Spent Sitting per Day
Functional Performance Among Participants With Per
Analyses adjusted for age, sex, race, body mass index, comorbidities, ankle brach
The reference group for pairwise comparisons was less than 4 h of sitting per day
†Pairwise p  0.054. **Pairwise p  0.019.without PAD (3,14). However, few treatments have beenidentified that improve functional performance in PAD.
Supervised treadmill exercise therapy significantly increases
treadmill walking performance in patients with PAD (4,26),
but few patients participate, in part because medical insur-
ance typically does not pay for this therapy (5). Home-based
exercise interventions do not have demonstrated efficacy in
patients with PAD (27). Identifying modifiable lifestyle
behaviors associated with slower functional decline in pa-
tients with PAD provides opportunities to test interventions
that modify behavior in an effort to improve functional
performance and/or reduce functional decline in PAD.
Patients with PAD can potentially reduce the number of
hours they spend sitting or being sedentary per day, even
without participating in exercise programs. Interventions
that reduce the number of hours spent seated or sedentary
per day may be more acceptable to patients with PAD than
interventions attempting to increase exercise behavior (26).
Our results also showed that among participants with
PAD, slower walking speed outside the home was associ-
ated with greater decline in calf muscle density at 4-year
follow-up, compared with faster walking speed outside the
home. This association was independent of age, sex, race,
Decline in
al Arterial Disease
ex, smoking, study cohort, leg symptoms, and prior year performance (N  384).
*Pairwise p  0.052. **Pairwise p  0.054. Bottom: *Pairwise p  0.02.With
ipher
ial ind
. Top:BMI, comorbidities, and ABI. Lower calf muscle density
2362 McDermott et al. JACC Vol. 57, No. 23, 2011
Sedentary Behavior and Functional Decline in PAD June 7, 2011:2356–64has been previously associated with higher rates of mobility
loss in patients with PAD (6). Thus, calf muscle density is
a meaningful outcome in patients with PAD (6).
Walking speed outside the home is also a modifiable
behavior but may be more difficult for patients with PAD to
change than the number of sedentary hours per day. This is
because walking speed outside the home is determined in
part by functional ability. Furthermore, increasing walking
speed outside the home may induce ischemic pain in
patients with PAD. Nonetheless, our data suggest that
encouraging patients with PAD to increase their walking
speed outside the home may prevent decline in calf muscle
density. Further study is needed to identify interventions
that increase walking speed outside the home and to
determine whether these interventions prevent declines in
calf muscle density and other outcomes in patients with
PAD.
Previous studies in people without PAD have demon-
strated that greater sitting hours per day are associated with
weight gain and incident diabetes mellitus (10,11,28).
However, to our knowledge, associations of sedentary hours
per day with clinically important outcomes have not been
Figure 2 Adjusted Associations of Total Sedentary Hours per D
Functional Decline Among Participants With Periphera
Analyses adjusted for age, sex, race, body mass index, comorbidities, ankle brach
The reference group for pairwise comparisons was 4 sedentary h/day. Top: *Pairwis
**Pairwise p  0.008.evaluated previously in patients with PAD. Because patientswith PAD have lower physical activity levels, greater func-
tional impairment, and faster functional decline than people
without PAD (1–3), prior studies linking greater sedentary
behavior to more adverse outcomes may not be generalizable
to patients with PAD.
Our findings are consistent with previous studies demon-
strating that lower physical activity levels during daily life,
measured with a vertical accelerometer over 7 days, are
associated with higher rates of faster functional decline in
people with PAD (23,24). However, vertical accelerometers
measure both quantity and intensity of vertical motion.
Vertical accelerometers do not measure activities performed
standing or sitting that do not include vertical movement.
We observed no correlation between the numbers of hours
spent sitting per day with vertical accelerometer–measured
physical activity. We observed only a modest correlation of
total sedentary hours per day with vertical accelerometer–
measured physical activity levels. Because nonsedentary
hours include standing and light activity, it is possible to
reduce the number of sedentary hours per day without
substantially altering physical activity.
Our finding that greater sedentary hours per day were
ith
erial Disease
ex, smoking, study cohort, leg symptoms, and prior year performance (N  384).
0.034. Bottom: *Pairwise p  0.034. †Pairwise p  0.001. ‡Pairwise p  0.037.ay W
l Art
ial ind
e p associated with faster decline in functional performance but
alking
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causal pathway for the association of greater sedentary hours
with faster functional decline is not likely to be mediated by
adverse calf muscle characteristics. Instead, the association
of greater sedentary hours per day with faster functional
decline may be mediated by worsening cardiovascular fit-
ness, greater inflammation, worsening calf muscle mito-
chondrial function, or greater progression of lower-
extremity atherosclerosis among participants with PAD
who were more sedentary. Similarly, our finding that slower
walking speed outside the home was associated with greater
declines in calf muscle density but no change in functional
performance measures suggests that declines in calf muscle
density associated with slower walking speed outside the
home are insufficient to cause changes in functional perfor-
mance over the 4-year follow-up. However, at baseline,
slower walking speeds outside the home were associated
with markedly lower levels of functional performance. It
may be that associations of slower walking speed outside the
home with poorer functional performance develop over
many years and that additional declines in functional per-
formance among those with slowest walking speeds were
not observable because of a floor effect related to the
association with baseline walking speed outside the home
and poor baseline functional performance. Longer
follow-up periods may be needed to demonstrate significant
associations of slower walking speed with average annual
functional decline among patients with PAD.
Study limitations. First, data were observational. Signifi-
cant associations cannot be construed as causal. Second,
participants were identified from an academic medical
center. Findings may not be generalizable to participants
Adjusted Associations of Total Sitting Hours per Day, Total SedentOutsid the Home With Change in Calf M scle Ch racteristics AmTable 3 Adjusted Associ tions of Total Sitting Hours per Day,Outside the Home With Change in Calf Muscle Charac
Average Annual Changes in
Calf Muscle Characteristics
No Walking
Outside the Home
(n  12)
Casual S
(0–2 m
(n 
Walking speed outside the home
Calf muscle area, mm2/yr 381 291
Calf muscle percent fat, %/yr 1.25 1
Calf muscle density, g/cm3/yr 1.43* 1
Hours spent sitting per day
Average annual declines 4 h (n  49) 4–7 h (n
Calf muscle area, mm2/yr 285 309
Calf muscle percent fat, %/yr 0.74 1
Calf muscle density, g/cm3/yr 0.92 0
Total sedentary hours (sitting and lying down) per day
Average annual declines 10 h (n  31) 10 to 14 h
Calf muscle area, mm2/yr 284 323
Calf muscle percent fat, %/yr 0.99 1
Calf muscle density, g/cm3/yr 0.69 0
Analyses adjusted for age, sex, race, tibia length (muscle area only), prior year muscle measurem
N  437. *p  0.060 for the pairwise comparison between no walking outside the home and a w
a walking speed of brisk or striding.with PAD outside of this setting. Third, the mechanisms ofassociations reported here were not discernable from data
collected in this study.
Conclusions
Among people with PAD, greater hours spent sitting per
day and greater total sedentary hours per day are associ-
ated with faster functional decline. Slower walking speed
outside the home is associated with greater declines in
calf muscle density. Reducing the number of sedentary
hours per day and increasing walking speed outside the
home are modifiable behaviors that may be more readily
adopted by patients with PAD than interventions de-
signed to promote exercise. Further study is needed to
determine whether reducing sedentary hours per day can
slow decline in objective measures of functional perfor-
mance in PAD. Further study is also needed to determine
whether interventions that increase walking speed outside
the home can prevent declines in calf muscle density in
people with PAD.
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